Literature DB >> 20807643

The roles of chondroitin-4-sulfotransferase-1 in development and disease.

Michael Klüppel1.   

Abstract

The glycosaminoglycan chondroitin sulfate (CS) consists of long linear chains of repeating disaccharide units, which are covalently attached to core proteins to form CS-proteoglycans. These molecules have been shown to fulfill important biological functions in development, disease, and signaling. Biosynthesis of CS takes place in the Golgi apparatus. Concomitant to chondroitin chain elongation, sulfation of specific carbon residues by chondroitin sulfotransferase enzymes takes place. The sulfation balance and pattern of CS on specific carbon residues are tightly regulated during development, injury, and disease, with the temporal and spatial expression of chondroitin sulfotransferase genes believed to be a crucial determinant of this fine balance of chondroitin sulfation. Chondroitin-4-sulfotransferase-1 (C4ST-1)/carbohydrate sulfotransferase 11 (CHST11) is one of the enzymes involved in the sulfation of chondroitin by catalyzing the transfer of sulfate groups from a sulfate donor to the carbon-4 position of the N-acetylgalactosamine sugar of the repeating disaccharide units. Here, I summarize the significant recent advances in our understanding of the roles of C4ST-1 in vertebrate development, disease, and signaling pathways, and the transcriptional regulation of the C4ST-1 gene. Proper 4-sulfation of chondroitin by C4ST-1 plays a crucial role in the skeletal development and signaling events, and new evidence is suggestive of a potential role for C4ST-1 in human disease, including cancer.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20807643     DOI: 10.1016/S1877-1173(10)93006-8

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  22 in total

1.  C4ST-1/CHST11-controlled chondroitin sulfation interferes with oncogenic HRAS signaling in Costello syndrome.

Authors:  Michael Klüppel; Payman Samavarchi-Tehrani; Kela Liu; Jeffrey L Wrana; Aleksander Hinek
Journal:  Eur J Hum Genet       Date:  2012-02-08       Impact factor: 4.246

2.  Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.

Authors:  Anurag Purushothaman; Bryan P Toole
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

3.  Genomic profiling in locally advanced and inflammatory breast cancer and its link to DCE-MRI and overall survival.

Authors:  Sharareh Siamakpour-Reihani; Kouros Owzar; Chen Jiang; Peter M Scarbrough; Oana I Craciunescu; Janet K Horton; Holly K Dressman; Kimberly L Blackwell; Mark W Dewhirst
Journal:  Int J Hyperthermia       Date:  2015-03-26       Impact factor: 3.914

4.  Fell-Muir Lecture: chondroitin sulphate glycosaminoglycans: fun for some and confusion for others.

Authors:  Bruce Caterson
Journal:  Int J Exp Pathol       Date:  2012-02       Impact factor: 1.925

5.  Inhibition by chondroitin sulfate E can specify functional Wnt/β-catenin signaling thresholds in NIH3T3 fibroblasts.

Authors:  Catherine M Willis; Michael Klüppel
Journal:  J Biol Chem       Date:  2012-08-22       Impact factor: 5.157

6.  CHST11/13 Regulate the Metastasis and Chemosensitivity of Human Hepatocellular Carcinoma Cells Via Mitogen-Activated Protein Kinase Pathway.

Authors:  Huimin Zhou; Yanping Li; Xiaobo Song; Yongfu Zhao; Lei Cheng; Lifen Zhao; Li Jia
Journal:  Dig Dis Sci       Date:  2016-03-18       Impact factor: 3.199

Review 7.  Insights from human genetic studies into the pathways involved in osteoarthritis.

Authors:  Louise N Reynard; John Loughlin
Journal:  Nat Rev Rheumatol       Date:  2013-08-20       Impact factor: 20.543

8.  Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study.

Authors:  Eleftheria Zeggini; Kalliope Panoutsopoulou; Lorraine Southam; Nigel W Rayner; Aaron G Day-Williams; Margarida C Lopes; Vesna Boraska; Tonu Esko; Evangelos Evangelou; Albert Hoffman; Jeanine J Houwing-Duistermaat; Thorvaldur Ingvarsson; Ingileif Jonsdottir; Helgi Jonnson; Hanneke J Kerkhof; Margreet Kloppenburg; Steffan D Bos; Massimo Mangino; Sarah Metrustry; P Eline Slagboom; Gudmar Thorleifsson; Emma V A Raine; Madhushika Ratnayake; Michelle Ricketts; Claude Beazley; Hannah Blackburn; Suzannah Bumpstead; Katherine S Elliott; Sarah E Hunt; Simon C Potter; So-Youn Shin; Vijay K Yadav; Guangju Zhai; Kate Sherburn; Kate Dixon; Elizabeth Arden; Nadim Aslam; Phillippa-kate Battley; Ian Carluke; Sally Doherty; Andrew Gordon; John Joseph; Richard Keen; Nicola C Koller; Sheryl Mitchell; Fiona O'Neill; Ellen Paling; Mike R Reed; Fernando Rivadeneira; Diane Swift; Kirsten Walker; Bridget Watkins; Maggie Wheeler; Fraser Birrell; John P A Ioannidis; Ingrid Meulenbelt; Andres Metspalu; Ashok Rai; Donald Salter; Kari Stefansson; Unnur Stykarsdottir; André G Uitterlinden; Joyce B J van Meurs; Kay Chapman; Panos Deloukas; William E R Ollier; Gillian A Wallis; Nigel Arden; Andrew Carr; Michael Doherty; Andrew McCaskie; J Mark Willkinson; Stuart H Ralston; Ana M Valdes; Tim D Spector; John Loughlin
Journal:  Lancet       Date:  2012-07-03       Impact factor: 79.321

9.  PPARγ regulates expression of carbohydrate sulfotransferase 11 (CHST11/C4ST1), a regulator of LPL cell surface binding.

Authors:  Ismayil Tasdelen; Ruud Berger; Eric Kalkhoven
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

10.  Expression of glycosaminoglycan epitopes during zebrafish skeletogenesis.

Authors:  Anthony J Hayes; Ruth E Mitchell; Andrew Bashford; Scott Reynolds; Bruce Caterson; Chrissy L Hammond
Journal:  Dev Dyn       Date:  2013-04-29       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.